Mclean Hospital
Clinical trials sponsored by Mclean Hospital, explained in plain language.
-
Can a vitamin pill slow Alzheimer's? early trial tests brain fuel theory
Disease control OngoingThis early-stage study is testing whether a dietary supplement called nicotinamide riboside (a form of vitamin B3) can improve brain cell energy and reduce harmful stress in people with mild memory problems or early Alzheimer's disease. Researchers will give the supplement to 50 …
Phase: EARLY_PHASE1 • Sponsor: Mclean Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Brain scan trial aims to tame cocaine cravings
Disease control TerminatedThis study aimed to see if a medication called lorcaserin could help people with cocaine dependence by rebalancing brain chemistry. Researchers planned to use brain scans to measure if the drug reduced reactions to drug cues and impulsive behavior. The study was withdrawn before …
Phase: PHASE1 • Sponsor: Mclean Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
CBD tested to calm distress in Alzheimer's patients
Symptom relief OngoingThis small, early-stage study is testing whether a liquid CBD solution placed under the tongue can help reduce anxiety and agitation in older adults with mild memory problems or early Alzheimer's disease. The 12 participants will take the solution for eight weeks while researcher…
Phase: EARLY_PHASE1 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Apr 01, 2026 23:11 UTC
-
Scientists scan brains to unlock clues for treating bipolar depression
Knowledge-focused OngoingThis study aims to understand how a magnetic stimulation treatment affects the brain in older adults with bipolar depression. Researchers will use brain scans before and after treatment to measure changes in brain activity. The goal is to gather information that could help guide …
Phase: NA • Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Could a single drug block stress from causing depression?
Knowledge-focused TerminatedThis study aimed to understand if a drug called LY-2940094 could protect healthy people from developing depression- and anxiety-like symptoms after stress. Researchers planned to give the drug to volunteers and then measure their brain's reward system and fear responses in a lab …
Phase: PHASE2 • Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Brain scans could predict future depression relapse
Knowledge-focused OngoingThis study aims to understand how people who have recovered from major depression make decisions and which brain areas are involved. Researchers will use MRI brain scans and decision-making tasks to see if they can predict who might experience depression symptoms in the future. T…
Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Scientists scan brains to unlock Trauma's hidden scars
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how childhood trauma affects the brain in women with PTSD or dissociative identity disorder. Researchers will use brain scans and genetic tests to look for patterns linked to dissociative symptoms. The study involves 200 women and includes follow-up …
Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC